Bionano Genomics (BNGO) Retained Earnings (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Retained Earnings for 9 consecutive years, with -$719.6 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 2665285.19% to -$719.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$719.6 million through Dec 2025, down 2665285.19% year-over-year, with the annual reading at -$719.6 million for FY2025, 2665285.19% down from the prior year.
- Retained Earnings hit -$719.6 million in Q4 2025 for Bionano Genomics, down from -$711.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $27000.0 in Q4 2024 to a low of -$719.6 million in Q4 2025.
- Historically, Retained Earnings has averaged -$358.2 million across 5 years, with a median of -$313.5 million in 2022.
- Biggest five-year swings in Retained Earnings: skyrocketed 100.0% in 2024 and later crashed 2665285.19% in 2025.
- Year by year, Retained Earnings stood at -$216.1 million in 2021, then tumbled by 61.35% to -$348.7 million in 2022, then tumbled by 66.67% to -$581.2 million in 2023, then surged by 100.0% to $27000.0 in 2024, then plummeted by 2665285.19% to -$719.6 million in 2025.
- Business Quant data shows Retained Earnings for BNGO at -$719.6 million in Q4 2025, -$711.7 million in Q3 2025, and -$703.2 million in Q2 2025.